title: Mechanisms regulating resistance to inhibitors of topoisomerase II.
abstract: Inhibitors of topoisomerase II (topo II) are clinically effective in the management of hematological malignancies and solid tumors. The efficacy of anti-tumor drugs targeting topo II is often limited by resistance and studies with in vitro cell culture models have provided several insights on potential mechanisms. Multidrug transporters that are involved in the efflux and consequently reduced cytotoxicity of diverse anti-tumor agents suggest that they play an important role in resistance to clinically active drugs. However, in clinical trials, modulating the multidrug-resistant phenotype with agents that inhibit the efflux pump has not had an impact. Since reduced drug accumulation per se is insufficient to explain tumor cell resistance to topo II inhibitors several studies have focused on characterizing mechanisms that impact on DNA damage mediated by drugs that target the enzyme. Mammalian topo IIα and topo IIβ isozymes exhibit similar catalytic, but different biologic, activities. Whereas topo IIα is associated with cell division, topo IIβ is involved in differentiation. In addition to site specific mutations that can affect drug-induced topo II-mediated DNA damage, post-translation modification of topo II primarily by phosphorylation can potentially affect enzyme-mediated DNA damage and the downstream cytotoxic response of drugs targeting topo II. Signaling pathways that can affect phosphorylation and changes in intracellular calcium levels/calcium dependent signaling that can regulate site-specific phosphorylation of topoisomerase have an impact on downstream cytotoxic effects of topo II inhibitors. Overall, tumor cell resistance to inhibitors of topo II is a complex process that is orchestrated not only by cellular pharmacokinetics but more importantly by enzymatic alterations that govern the intrinsic drug sensitivity.
authors.affiliation: Levine Cancer Institute, Carolinas HealthCare System Charlotte, NC, USA.
authors.forename: Ram N
authors.initials: RN
authors.lastname: Ganapathi
authors.forename: Mahrukh K
authors.initials: MK
authors.lastname: Ganapathi
keywords: calmodulin inhibitors; casein kinase I; drug resistance; topo II phosphorylation; topoisomerase II
references.citation: Exp Cell Res. 1994 Feb;210(2):336-48
references.pmid: 8299728
references.citation: Br J Cancer. 1994 Apr;69(4):687-97
references.pmid: 8142256
references.citation: Cancer Res. 1993 Oct 15;53(20):4866-73
references.pmid: 8104687
references.citation: Curr Cancer Drug Targets. 2010 Nov;10(7):758-71
references.pmid: 20578986
references.citation: J Biol Chem. 2001 Mar 16;276(11):8029-36
references.pmid: 11115510
references.citation: Biochem Pharmacol. 1991 Jun 21;42(1):77-85
references.pmid: 1648924
references.citation: Breast Cancer Res Treat. 2011 Oct;129(3):839-48
references.pmid: 21809115
references.citation: Cancer Res. 1983 Aug;43(8):3696-9
references.pmid: 6861140
references.citation: J Biol Chem. 1991 Apr 25;266(12):7957-61
references.pmid: 1850428
references.citation: Biochemistry. 1989 Oct 3;28(20):8154-60
references.pmid: 2557897
references.citation: Biochemistry. 1987 Oct 6;26(20):6402-6
references.pmid: 2827726
references.citation: Cancer Res. 1998 Dec 1;58(23):5298-300
references.pmid: 9850052
references.citation: J Biol Chem. 1994 Oct 7;269(40):24523-6
references.pmid: 7929118
references.citation: J Biol Chem. 1989 Oct 5;264(28):16524-9
references.pmid: 2550447
references.citation: Cancer Res. 1991 Aug 1;51(15):3951-7
references.pmid: 1649696
references.citation: J Natl Cancer Inst. 1975 Dec;55(6):1265-74
references.pmid: 1107570
references.citation: Cancer Res. 1993 Mar 1;53(5):1064-71
references.pmid: 8382551
references.citation: Mol Pharmacol. 1991 Jan;39(1):1-8
references.pmid: 1670962
references.citation: Biochem J. 1994 Nov 1;303 ( Pt 3):681-95
references.pmid: 7980433
references.citation: Cancer Invest. 2006 Nov;24(7):677-81
references.pmid: 17118777
references.citation: Biochemistry. 1986 Apr 22;25(8):2248-56
references.pmid: 3011082
references.citation: Cancer Res. 1993 Mar 15;53(6):1373-9
references.pmid: 8383009
references.citation: Pharmacol Rev. 1990 Sep;42(3):155-99
references.pmid: 2217530
references.citation: J Biol Chem. 1989 Jun 15;264(17):9713-5
references.pmid: 2542330
references.citation: Blood. 2010 Sep 2;116(9):1413-21
references.pmid: 20522709
references.citation: Biochemistry. 1987 Jul 14;26(14):4303-9
references.pmid: 2822084
references.citation: Biochemistry. 1994 Dec 13;33(49):14651-5
references.pmid: 7993892
references.citation: J Biol Chem. 1989 Sep 15;264(26):15161-4
references.pmid: 2549053
references.citation: Cancer Res. 1994 Nov 15;54(22):5902-10
references.pmid: 7954421
references.citation: Proc Natl Acad Sci U S A. 1989 Dec;86(23):9431-5
references.pmid: 2556712
references.citation: Biochem Pharmacol. 1996 Dec 24;52(12):1903-9
references.pmid: 8951349
references.citation: Cancer Res. 1970 Apr;30(4):1174-84
references.pmid: 5533992
references.citation: Cancer Res. 1968 May;28(5):938-41
references.pmid: 5652307
references.citation: Biochem Pharmacol. 1988 Jan 15;37(2):185-93
references.pmid: 3342075
references.citation: Proc Natl Acad Sci U S A. 1985 May;82(10):3164-8
references.pmid: 2987912
references.citation: Biochemistry. 1990 Jan 16;29(2):583-90
references.pmid: 2154252
references.citation: J Biol Chem. 1995 Sep 15;270(37):21429-32
references.pmid: 7665550
references.citation: J Clin Oncol. 2010 Feb 20;28(6):984-90
references.pmid: 20038724
references.citation: J Biol Chem. 1994 Jan 14;269(2):1173-6
references.pmid: 8288578
references.citation: Br J Cancer. 1988 Sep;58(3):335-40
references.pmid: 3179186
references.citation: Mol Pharmacol. 1994 Jul;46(1):58-66
references.pmid: 8058057
references.citation: Cancer Res. 1991 Sep 1;51(17):4729-31
references.pmid: 1651812
references.citation: Annu Rev Pharmacol Toxicol. 1994;34:191-218
references.pmid: 8042851
references.citation: Annu Rev Biochem. 1989;58:137-71
references.pmid: 2570548
references.citation: Anticancer Drugs. 1992 Aug;3(4):323-30
references.pmid: 1330080
references.citation: Cancer Res. 1990 May 15;50(10):2901-8
references.pmid: 2159365
references.citation: Biochem J. 1993 Jul 1;293 ( Pt 1):297-304
references.pmid: 8392338
references.citation: Pharmacol Ther. 1990;47(3):359-70
references.pmid: 2290853
references.citation: Cancer Res. 1996 Mar 15;56(6):1232-6
references.pmid: 8640804
references.citation: Cancer Res. 1990 Nov 1;50(21):6919-24
references.pmid: 1698546
references.citation: Cancer. 1993 Dec 1;72(11 Suppl):3502-14
references.pmid: 7902206
references.citation: Nucleic Acids Res. 2009 Feb;37(2):382-92
references.pmid: 19043076
references.citation: Oncol Res. 1995;7(2):103-11
references.pmid: 7579726
references.citation: Proc Natl Acad Sci U S A. 1986 Mar;83(6):1603-7
references.pmid: 3006058
references.citation: Mol Pharmacol. 1996 Aug;50(2):243-8
references.pmid: 8700130
references.citation: Cancer Invest. 1994;12(5):530-42
references.pmid: 7922710
references.citation: Lancet Oncol. 2011 Nov;12(12):1134-42
references.pmid: 21917518
references.citation: Oncology. 2011;80(3-4):269-77
references.pmid: 21734419
references.citation: J Biol Chem. 1996 May 3;271(18):10990-5
references.pmid: 8631919
references.citation: Breast Cancer Res Treat. 2011 Jul;128(2):401-9
references.pmid: 21519837
references.citation: Cancer Treat Res. 1989;48:55-72
references.pmid: 2577141
references.citation: Biochim Biophys Acta. 1993 Nov 16;1216(2):191-6
references.pmid: 8241259
references.citation: Pathol Res Pract. 2010 Mar 15;206(3):156-62
references.pmid: 20089371
references.citation: J Cell Sci. 1993 Feb;104 ( Pt 2):219-25
references.pmid: 8389373
references.citation: Adv Enzymol Relat Areas Mol Biol. 1988;61:149-200
references.pmid: 2833077
references.citation: Biochemistry. 1990 May 1;29(17):4235-41
references.pmid: 2163274
references.citation: EMBO J. 1992 May;11(5):1785-96
references.pmid: 1316274
references.citation: Cell Growth Differ. 1991 Apr;2(4):209-14
references.pmid: 1651102
references.citation: Br J Cancer. 1989 Dec;60(6):819-26
references.pmid: 2605093
references.citation: Biochem Biophys Res Commun. 1993 May 14;192(3):1274-80
references.pmid: 8389546
references.citation: Cancer Res. 1991 Dec 15;51(24):6592-5
references.pmid: 1660343
references.citation: Cancer Res. 1994 Feb 1;54(3):756-62
references.pmid: 8306338
references.citation: J Cell Sci. 1993 Feb;104 ( Pt 2):533-43
references.pmid: 8389377
references.citation: Biochem Pharmacol. 1991 Jun 15;41(12):R21-6
references.pmid: 1674871
references.citation: Br J Cancer. 1996 Jan;73(2):183-8
references.pmid: 8546904
references.citation: Cancer Res. 1982 Nov;42(11):4730-3
references.pmid: 7127307
references.citation: Biochemistry. 1987 Jul 14;26(14):4338-44
references.pmid: 2822085
references.citation: Cancer Res. 1984 Nov;44(11):5056-61
references.pmid: 6488165
references.citation: Biochem Pharmacol. 1994 Nov 1;48(9):1785-95
references.pmid: 7980648
references.citation: Cancer Treat Rep. 1984 Jan;68(1):87-99
references.pmid: 6198082
references.citation: Breast Cancer Res Treat. 2012 Feb;132(1):225-34
references.pmid: 22160637
references.citation: Biochem J. 1995 Nov 15;312 ( Pt 1):197-204
references.pmid: 7492313
references.citation: Biochem Pharmacol. 1986 Feb 1;35(3):467-72
references.pmid: 3947382
references.citation: Cancer Res. 1987 Jul 1;47(13):3464-8
references.pmid: 2884031
references.citation: J Biol Chem. 1994 Nov 25;269(47):29746-51
references.pmid: 7961967
references.citation: Cancer Treat Rev. 2009 Dec;35(8):662-7
references.pmid: 19758759
references.citation: J Cell Physiol. 1974 Feb;83(1):103-16
references.pmid: 4855907
references.citation: Mol Pharmacol. 1995 Nov;48(5):798-805
references.pmid: 7476909
references.citation: J Clin Invest. 1982 Nov;70(5):1131-4
references.pmid: 6182160
references.citation: Nature. 1986 Jul 10-16;322(6075):187-9
references.pmid: 3014353
references.citation: Biochemistry. 1991 Oct 15;30(41):9953-61
references.pmid: 1655025
references.citation: Adv Cancer Res. 1993;60:157-80
references.pmid: 8417499
references.citation: Cytotechnology. 1993;12(1-3):109-25
references.pmid: 7765322
references.citation: Biochemistry. 1992 Jan 21;31(2):359-63
references.pmid: 1310036
references.citation: Cancer Res. 1992 Apr 15;52(8):2156-61
references.pmid: 1313738
references.citation: Biochem Pharmacol. 1985 Mar 1;34(5):593-8
references.pmid: 3856430
references.citation: J Biol Chem. 2003 Apr 11;278(15):12696-702
references.pmid: 12569090
references.citation: Clin Cancer Res. 2010 Apr 15;16(8):2391-401
references.pmid: 20371687